Moderator: Patrick C. Hsieh, MD
1. Intravenous and Oral Tranexamic Acid are Equivalent at Reducing Blood Loss in Thoracolumbar Spinal Fusion: A Prospective Randomized Trial
Charles C. Yu, MD1; Mohsin S. Fidai, MD1; Omar Kadri, MD2; Allen A. Kadado, MD3; Jacob A. Pawloski, BS4; Morenikeji Buraimoh, MD5; Stephen Bartol, MD, MBA, FRCSC6
1Henry Ford Health System, Detroit, MI, US; 2Henry Ford Hospital, Detroit, MI, US; 3Detroit, MI, US; 4Wayne State University School of Medicine, Detroit, MI, US; 5Centers for Advanced Orthopaedics, OrthoMaryland, Baltimore, MD, US; 6Windsor, ON, Canada
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
2. Preserving the Spine Motion in Degenerative Lumbar Spine
Aloysius B. Darwono, MD, PhD
Jakarta, Utara, Indonesia
FDA Device/Drug Status: not FDA approved (Not approved for this indication)
3. PROMIS-29 Validity and Conversion Equation to Oswestry Disability Index (ODI) Using a National Sample of Lumbar Spine Surgery Patients
Jacquelyn S. Pennings, PhD; Clinton J. Devin, MD; Kristin R. Archer, PhD, DPT
Vanderbilt University Medical Center, Nashville, TN, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
4. A Novel Intraoperative Radiographic Assessment Method for Evaluating Indirect Decompression in Oblique Lumbar Interbody Fusion
Jin-Sung L. Kim, MD, PhD
Seoul St. Mary's Hospital, Seocho Gu, Seoul, Republic of Korea
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
5. Evaluating the Thrombosis Risk of Tranexamic Acid Administration in Spine Surgery
Ishaan Sachdeva, BS1; Jonathan J. Carmouche, MD2
1Virginia Tech Carilion School of Medicine, Roanoke, VA, US; 2Carilion Clinic, Roanoke, VA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
6. Moved to ePoster
Discussion
7. The Predictive Value of Postoperative Anemia on Length of Stay for Patients Undergoing Minimally Invasive Lumbar Fusion
Ishaan Sachdeva, BS1; Jonathan J. Carmouche, MD2
1Virginia Tech Carilion School of Medicine, Roanoke, VA, US; 2Carilion Clinic, Roanoke, VA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
8. Predicting Hospital Length of Stay for Patients Undergoing Minimally Invasive Lumbar Fusion Based on Occupational Therapy and Physical Therapy Evaluations of Postoperative Mobility
Ishaan Sachdeva, BS1; Jonathan J. Carmouche, MD2
1Virginia Tech Carilion School of Medicine, Roanoke, VA, US; 2Carilion Clinic, Roanoke, VA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
9. Fusion Rates and Incidence of Inner and Outer Intervertebral Bone Bridge Following Lateral Lumbar Interbody Fusion in Multilevel Instrumented Spinal Surgery
Yu Moriguchi, MD
Department of Orthopaedics, Osaka University Graduate School of Medicine, Suita, Japan
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
10. Biportal Endoscopic Decompression for Lumbar Foraminal Stenosis
Jinhwa Eum, MD
Bumin Hospital, Busan, Busan, Republic of Korea
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
11. Preliminary Learning Cases of Unilateral Biportal Endoscopic Spine Surgery (UBE) in Stenosis and Disc Protrusions
Seung Deok Sun, MD
Sun's Orthopedics, Seoul, South Korea
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
12. Correlations Among PROMIS-29 Domains Before and After Lumbar Spine Surgery
Jacquelyn S. Pennings, PhD; Inamullah Khan, MD; Clinton J. Devin, MD; Kristin R. Archer, PhD, DPT
Vanderbilt University Medical Center, Nashville, TN, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion